Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Return on Sales: 2014-2017

Historic Return on Sales for Tvardi Therapeutics (TVRD) over the last 2 years, with Mar 2017 value amounting to -20.02%.

  • Tvardi Therapeutics' Return on Sales fell 1196.00% to -20.02% in Q1 2017 from the same period last year, while for Mar 2017 it was -20.02%, marking a year-over-year decrease of 1196.00%. This contributed to the annual value of -666.05% for FY2016, which is 65955.00% down from last year.
  • Latest data reveals that Tvardi Therapeutics reported Return on Sales of -20.02% as of Q1 2017, which was down 78.69% from -11.20% recorded in Q2 2016.
  • Tvardi Therapeutics' 5-year Return on Sales high stood at -4.10% for Q3 2015, and its period low was -20.02% during Q1 2017.
  • In the last 3 years, Tvardi Therapeutics' Return on Sales had a median value of -7.13% in 2016 and averaged -9.17%.
  • Its Return on Sales has fluctuated over the past 5 years, first spiked by 74bps in 2015, then slumped by 1,196bps in 2017.
  • Tvardi Therapeutics' Return on Sales (Quarterly) stood at -5.59% in 2014, then surged by 74bps to -4.10% in 2015, then crashed by 500bps to -11.20% in 2016, then crashed by 1,196bps to -20.02% in 2017.
  • Its Return on Sales was -20.02% in Q1 2017, compared to -11.20% in Q2 2016 and -8.06% in Q1 2016.